4//SEC Filing
Janda Kim 4
Accession 0001209191-21-055954
CIK 0000850261other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:00 PM ET
Size
9.2 KB
Accession
0001209191-21-055954
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-13$3.50/sh+8,000$28,000→ 11,000 total - Sale
Common Stock
2021-09-13$8.04/sh−8,000$64,285→ 3,000 total - Exercise/Conversion
Non-qualified stock option
2021-09-13−8,000→ 0 totalExercise: $3.50Exp: 2021-09-28→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.84 to $8.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]25% of the shares subject to the option vested on September 28, 2012, and 1/48th of the shares subject to the option vested monthly thereafter.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001518466
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 5:00 PM ET
- Size
- 9.2 KB